Clinical Trial Update: Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating abemaciclib for Kaposi sarcoma in HIV-associated and HIV-negative patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kaposi Sarcoma | Phase 1, Phase 2 | Status: RECRUITING